BORTOT, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 462
EU - Europa 98
AS - Asia 90
SA - Sud America 9
AF - Africa 1
Totale 660
Nazione #
US - Stati Uniti d'America 460
SG - Singapore 42
RU - Federazione Russa 23
CN - Cina 21
IT - Italia 19
DE - Germania 17
VN - Vietnam 17
BR - Brasile 8
BE - Belgio 7
UA - Ucraina 7
IE - Irlanda 6
IN - India 6
FR - Francia 5
FI - Finlandia 4
AT - Austria 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
CA - Canada 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
NL - Olanda 1
PL - Polonia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 660
Città #
Chandler 61
Fairfield 48
Ashburn 45
Ann Arbor 33
Singapore 32
Seattle 28
Woodbridge 20
Houston 19
Wilmington 18
Cambridge 17
Dong Ket 17
New York 14
Boardman 12
Dearborn 8
Princeton 8
Brussels 7
Beijing 6
Dublin 6
Redmond 6
Jacksonville 5
Martignacco 5
Frankfurt am Main 4
Nanjing 4
San Diego 4
Helsinki 3
Jinan 3
Nuremberg 3
Scafati 3
Washington 3
Brno 2
Leawood 2
Los Angeles 2
Ogden 2
Phoenix 2
Udine 2
Arima 1
Asti 1
Atlanta 1
Augusta 1
Bento Gonçalves 1
Cairo 1
Camaçari 1
Campina Grande 1
Chongqing 1
Dallas 1
Des Moines 1
Divinópolis 1
Dushanbe 1
Hyderabad 1
Kunming 1
Lagoa dos Gatos 1
Langfang 1
Lappeenranta 1
Lauterbourg 1
London 1
Lucknow 1
Melfi 1
Milan 1
Munich 1
Nanchang 1
Newark 1
Norfolk 1
Nova Friburgo 1
Olive Branch 1
Parauapebas 1
Quito 1
Riga 1
San Remo 1
Santa Clara 1
Tel Aviv 1
Tokyo 1
Toronto 1
Trento 1
Wenzhou 1
Wuhan 1
Xaxim 1
Totale 495
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 137
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 112
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 105
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 96
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 80
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 68
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 48
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 41
Totale 687
Categoria #
all - tutte 3.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/2021179 8 11 25 33 9 18 8 13 6 10 14 24
2021/202279 11 9 0 1 1 0 6 2 0 10 31 8
2022/2023114 10 16 0 19 14 21 0 7 19 2 4 2
2023/202469 3 5 3 2 15 23 0 2 4 2 0 10
2024/2025138 2 9 7 10 13 8 17 9 24 13 22 4
Totale 687